Antibody-based therapeutics hold promise for treating the often deadly hemorrhagic fever caused by Ebola virus. During the current Ebola outbreak in West Africa, which has killed more than 1,500 people to date, several infected people have been treated with an experimental antibody-cocktail treatment called ZMapp. These antibodies are designed to neutralize Zaire ebolavirus, the cause … Continued